OccamzRazor

OccamzRazor combines machine learning and cutting-edge biotechnology to improve the outcomes of drug discovery and development. Our analytical process consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they aim to extract data from unstructured text sources (publications, patient-reported outcomes, etc.) and integrate them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. OccamzRazor was founded to help patients suffering from brain aging disorders, as these patients lack treatment options to prevent or reverse the disease.